$NVS

Stocks making the biggest moves premarket: General Motors, 3M, Novartis, Nebius & more

Premarket movers included Novartis, after Q2 core EPS of $2.41 beat $2.15 and revenue of $14.41B beat $13.95B, with full-year guidance on track. General Motors rose on adjusted EPS $3.57 vs $3.20 and revenue $48.03B vs $47.01B. Domino’s fell on EPS $4.07 vs $4.17. Nebius gained after Nvidia disclosed a 9.3% stake.

Original reporting
Published Jul 21, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 12:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stocks making the biggest moves premarket: General Motors, 3M, Novartis, Nebius & more — source image
Decision brief

The 30-second read

$NVSBullishMed
01

Why it matters

The actionable trading signal is the combination of quantified earnings results versus consensus and explicit forward-looking statements (guidance raises or “on track” language), plus one disclosed ownership catalyst (Nvidia stake) and one semi-pricing report.

02

Market read

Traders can use the quantified beats/misses and guidance language to frame open-to-close positioning, while treating sourced pricing reports and non-cash impairments as potentially lower-conviction catalysts.

03

What to watch

For TSM, the catalyst is sourced from Nikkei Asia and may not be finalized; for STLD, the impairment is non-cash, so traders may re-focus on underlying earnings power once the initial reaction passes.

Relevance 7/10Novelty 6/10Timing: pre-market ahead of the open

Background

This is a pre-bell multi-stock movers roundup summarizing why each company’s shares are moving, including earnings beats/misses, guidance changes, and a disclosed strategic stake.

Company-level read

Ticker impact

$NVSBullishMedium confidence
Context

Novartis shares jumped after Q2 core earnings and revenue beat estimates and management reiterated it remains on track for full-year guidance.

Expected impact

Likely continuation of premarket strength into the open, with volatility tied to any guidance interpretation.

Evidence & confidence

The article cites specific beat figures and an explicit “remains on track” statement, which typically anchors expectations for the next trading session.

$GMBullishMedium confidence
Context

General Motors gained more than 1% after adjusted Q2 EPS and revenue beat LSEG expectations.

Expected impact

Moderate likelihood of follow-through buying at the open, though magnitude may fade if broader market turns.

Evidence & confidence

The text provides a same-session earnings beat with quantified EPS and revenue versus consensus.

$DPZBearishMedium confidence
Context

Domino’s Pizza shares fell after Q2 EPS missed consensus, despite revenue slightly beating expectations.

Expected impact

Potential for continued weakness at the open, with downside limited if revenue quality is viewed favorably.

Evidence & confidence

The article explicitly attributes the move to the EPS miss versus LSEG consensus.

$MMMBullishHigh confidence
Context

3M shares jumped more than 5% after Q2 results beat expectations and the company raised full-year guidance.

Expected impact

Likely strong open and potential momentum, with traders watching for any details behind the guidance raise.

Evidence & confidence

The combination of beat plus explicit guidance increase is typically high-conviction for near-term repricing.

$TSMBullishLow confidence
Context

Taiwan Semiconductor Manufacturing shares popped after a report said the foundry will raise chipmaking services prices by up to 10% next year.

Expected impact

Sustained bid at the open is plausible, but could reverse if the report is viewed as non-binding or already priced.

Evidence & confidence

The catalyst is attributed to Nikkei Asia sources, and the article does not confirm whether the change is finalized.

$CCKBullishMedium confidence
Context

Crown Holdings climbed more than 2% after Q2 earnings and revenue beat analysts’ FactSet expectations.

Expected impact

Moderate chance of follow-through strength into the open.

Evidence & confidence

The article provides quantified EPS and revenue versus consensus and ties the move directly to the beat.

$STLDBearishMedium confidence
Context

Steel Dynamics dipped 1% despite an earnings beat, after posting an additional non-cash impairment charge of $16 million.

Expected impact

Likely choppy trading, with downside risk if investors focus on impairment magnitude rather than underlying earnings power.

Evidence & confidence

The article explicitly states the stock fell and attributes it to the additional impairment charge.

$CBRLBullishMedium confidence
Context

Cracker Barrel Old Country Store gained more than 1% after raising expectations to achieve or exceed the high end of its revenue range and exceed adjusted EBITDA outlook.

Expected impact

Potential for continued strength at the open, especially if traders treat it as a meaningful raise.

Evidence & confidence

The article includes specific forward-looking targets for fiscal 2026 and ties the move directly to that statement.

Market effects

Broad read-through to earnings season quality across pharma, autos, consumer, industrials, semis, and materials; pricing-power narrative in semis via TSM.

European AI/tech sentiment supported by Nvidia’s disclosed stake in Nebius; Swiss pharma strength via Novartis.

Semiconductor pricing expectations can influence global supply-chain cost assumptions and risk appetite for AI-related capex.

Counterpoint

Some moves may fade if investors treat guidance language or pricing reports as non-binding, or if impairment charges are viewed as one-off accounting noise.

Key entities

  • Novartis

    Q2 core earnings and revenue beat estimates; reiterated full-year guidance and midterm outlook remains on track.

  • General Motors

    Adjusted Q2 EPS and revenue beat LSEG expectations; shares gained more than 1%.

  • Domino’s Pizza

    Q2 EPS missed consensus while revenue slightly beat; shares dropped about 1%.

  • Nebius Group

    Rallied after Nvidia disclosed a 9.3% stake in the Amsterdam-based AI cloud company.

  • 3M

    Q2 beat and raised full-year guidance; shares jumped more than 5%.

Related articles

$TSMHigh

Moody’s upgrades TSMC outlook on AI demand, chip leadership

Moody’s affirmed TSMC’s Aa3 rating and revised its outlook to positive, citing strong AI demand and tech leadership. The agency expects 30-40% revenue growth and improved EBITDA margins over the next 12-18 months. TSMC’s cash position remains strong, and Moody’s notes potential upgrades if the company maintains its market position and financial health.

$FNHighAI 9/10

Beware of Nebius and Fabrinet

Nebius Group (NBIS) raised $5B via senior notes, including $3B of convertible notes due 2030 with an exercise price of $313.46, to expand its AI business. Its stock fell from $280 to $219. Fabrinet (FN) reported Q4 EPS of $4.10 and revenue up 45.1% Y/Y, but its stock dropped from over $600 to $436.67.

$NBISHighAI 8/10

Nebius Stock Price Forecast — NBIS ($227.00) Gaps 7% On Nvidia's $108B Guide — $268.85 Then $299.86 Upside

Nebius Group (NBIS) shares rose 7% in premarket trading, reaching $227.00, driven by Nvidia's strong earnings report and guidance. Nvidia reported $96.2B revenue and guided $108B for the next quarter, with 70% revenue growth expected in fiscal 2028. Nebius, which rents Nvidia silicon, saw increased demand and supply commitments. The stock has seen significant volatility recently, with a 454% revenue growth reported in Q2. Investors are watching to see if the premarket gains hold in regular tradi

$BMYLow

ACR: CMS rule on Medicare drug price negotiation could have ‘unintended consequences’

The American College of Rheumatology (ACR) warns that a proposed CMS rule on Medicare drug price negotiation may limit access to biologic drugs. The rule could create a 'payment gap' for physician-administered drugs, potentially leading to discontinued use. ACR supports the Protecting Patient Access to Cancer and Complex Therapies Act to address reimbursement issues. Drugs affected include Orencia (BMS), Cosentyx (Novartis), Xeljanz (Pfizer), and Cimzia (UCB).

$TSMMed

Why is Taiwan Semiconductor stock rallying today?

Taiwan Semiconductor (TSMC) stock rose 2.1% after Nvidia reported strong earnings, with $96.2B revenue and $108B Q3 guidance, signaling robust AI demand. TSMC, Nvidia's exclusive chipmaker, is seen as a key beneficiary. TSMC also confirmed manufacturing new chips for Xiaomi, expanding its revenue base. The Nasdaq and S&P 500 also gained, supporting the rally.